308 Nco I polymorphism of tumour necrosis factor α in overweight Caucasians
暂无分享,去创建一个
L. Heilbronn | M. Noakes | P. Clifton | K. Kind | A. Morris
[1] I. Caterson,et al. Association of the TNF-α−308 G/A Promoter Polymorphism with Insulin Resistance in Obesity , 2002 .
[2] E. Gabazza,et al. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. , 2002, Diabetes research and clinical practice.
[3] E. Brand,et al. Tumor necrosis factor-α−308 G/A polymorphism in obese Caucasians , 2001, International Journal of Obesity.
[4] T. Saruta,et al. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. , 2000, Metabolism: clinical and experimental.
[5] T. Hansen,et al. The -238 and -308 G-->A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. , 2000, The Journal of clinical endocrinology and metabolism.
[6] H. Häring,et al. The tumour necrosis factor alpha –238 G → A and –308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II Diabetic patients , 2000, Diabetologia.
[7] C. Yen,et al. Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance. , 1999, Diabetes.
[8] S. Chanock,et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. , 1998, The Journal of clinical investigation.
[9] M. Walker,et al. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance , 1998, Diabetologia.
[10] D. Arveiler,et al. Polymorphisms of the tumour necrosis factor‐α gene, coronary heart disease and obesity , 1998, European journal of clinical investigation.
[11] W. Ricart,et al. The TNF-α Gene Neo I Polymorphism Influences the Relationship Among Insulin Resistance, Percent Body Fat, and Increased Serum Leptin Levels , 1997, Diabetes.
[12] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[14] C. Mantzoros,et al. Genetic Variability in the TNF-α Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM) , 1995 .
[15] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[16] S. Rössner,et al. Excessive fat accumulation is associated with the TNFα–308 G/A promoter polymorphism in women but not in men , 2000, Diabetologia.
[17] S. Gapstur,et al. Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. , 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.